FDA inspection
Jubilant HollisterStier General Partnership: FDA inspection ending Jun 14, 2024
FDA inspection 1242347 · Official Action Indicated (OAI) · Kirkland
Key facts
| Inspection ID | 1242347 |
|---|---|
| Firm | Jubilant HollisterStier General Partnership |
| FEI number | 3001623073 |
| Address | 16751 Rte Transcanadienne |
| City | Kirkland |
| Country | Canada |
| Fiscal year | 2024 |
| Inspection end date | Jun 14, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data